ES2083167T3 - Sistemas de retardo mejorados para la liberacion retardada temporalmente de substancias de valor medico y/o biologico a partir de un material soporte de deposito. - Google Patents

Sistemas de retardo mejorados para la liberacion retardada temporalmente de substancias de valor medico y/o biologico a partir de un material soporte de deposito.

Info

Publication number
ES2083167T3
ES2083167T3 ES92908734T ES92908734T ES2083167T3 ES 2083167 T3 ES2083167 T3 ES 2083167T3 ES 92908734 T ES92908734 T ES 92908734T ES 92908734 T ES92908734 T ES 92908734T ES 2083167 T3 ES2083167 T3 ES 2083167T3
Authority
ES
Spain
Prior art keywords
pct
retard
materials
polymer compounds
hydroxycarboxylic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92908734T
Other languages
English (en)
Inventor
Wolfgang Ritter
Rudolf Lehmann
Rainer Sorg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Application granted granted Critical
Publication of ES2083167T3 publication Critical patent/ES2083167T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31786—Of polyester [e.g., alkyd, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL OBJETO DE LA INVENCION ES EN UNA PRIMERA TOMA DE REALIZACION LA APLICACION DE COMPONENTES DE RETICULANTES REACTIVOS RADICALMENTE A BASE DE ESTERES INSATURADOS OLEFINICAMENTE DE ACIDOS HIDROXICARBOXILCOS DE BAJO NUMERO DE CARBONOS Y/O SUS OLIGOMEROS PARA MODIFICAR MATERIALES-DEPOSITOS PARTICULARMENTE SISTEMA DE RETARDADO QUE CONTIENE LA SUSTANCIA ACTIVA MEDICINAL Y/O BIOLOGICA EN MEZCLA CON UN MATERIAL-PORTADOR CON EMISION RETARDADA TEMPORALMENTE DE SUBSTANCIA ACTIVA EN LA PRACTICA. EL RETICULANTE PRESENTA EN LA FORMA DE APLICACION DEL SISTEMA RETARDADO COMO COMPUESTOS POLIMERICOS Y PUEDE DISPONERSE CONSIDERABLEMENTE EN DISTRIBUCION HOMOGENEA O TAMBIEN DESIGUALES EN MATERIAL-DEPOSITOS DE LOS SISTEMAS DE RETARDADO A APLICAR. CON ARREGLO A LA INVENCION SON SISTEMAS RETARDADOS CONTENIENDO MATERIA VALIOSA BIOLOGICA Y/O MEDICINAL A BASE DE COMPUESTOS OLIGOMERICOS O POLIMERICOS DE ACIDOS HIDROXICARBOXILICOS DE BAJO NUMERO DE CARBONOS COMO MATERIAL PORTADOR CON EMISION LIBRE Y TEMPORALMENTE RETARDADA DE SUBSTANCIA ACTIVA. LAS CARACTERISTICAS DE LA INVENCION SON, YA QUE ESTE SISTEMA RETARDADO POR EJEMPLO DE MATERIALES-DEPOSITOS SE MODIFICA CON COMPUESTOS POLIMERICOS DE ESTERES INSATURADOS OLEFINICOS DE ACIDOS HIDROXICARBOXILICOS DE BAJO NUMERO DE CARBONOS Y/O LOS OLIGOMEROS.
ES92908734T 1991-04-17 1992-04-11 Sistemas de retardo mejorados para la liberacion retardada temporalmente de substancias de valor medico y/o biologico a partir de un material soporte de deposito. Expired - Lifetime ES2083167T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4112464A DE4112464A1 (de) 1991-04-17 1991-04-17 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial

Publications (1)

Publication Number Publication Date
ES2083167T3 true ES2083167T3 (es) 1996-04-01

Family

ID=6429738

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92908734T Expired - Lifetime ES2083167T3 (es) 1991-04-17 1992-04-11 Sistemas de retardo mejorados para la liberacion retardada temporalmente de substancias de valor medico y/o biologico a partir de un material soporte de deposito.

Country Status (14)

Country Link
US (1) US5538738A (es)
EP (1) EP0580689B1 (es)
JP (1) JP3351523B2 (es)
AT (1) ATE133857T1 (es)
AU (1) AU661303B2 (es)
BR (1) BR9205903A (es)
CA (1) CA2108680A1 (es)
DE (2) DE4112464A1 (es)
DK (1) DK0580689T3 (es)
ES (1) ES2083167T3 (es)
FI (1) FI934569A0 (es)
GR (1) GR3019522T3 (es)
NO (1) NO933345D0 (es)
WO (1) WO1992018108A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646782C2 (de) * 1996-11-13 2000-05-25 Merck Patent Gmbh Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
GB0007419D0 (en) † 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
CZ294328B6 (cs) * 2002-08-22 2004-11-10 Pliva-Lachema A. S. Biodegradabilní kompozice s prolongovaným uvolňováním biologicky aktivní látky a způsob její výroby
US7544192B2 (en) * 2003-03-14 2009-06-09 Sinexus, Inc. Sinus delivery of sustained release therapeutics
CA2603081C (en) 2005-04-04 2013-09-03 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
CA2614187A1 (en) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
DK2231065T3 (da) 2007-12-18 2021-02-01 Intersect Ent Inc Selvekspanderende anordninger
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
EP2370060B1 (en) 2008-11-27 2017-05-03 B.R.A.I.N. Biotechnology Research and Information Network AG Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
EP3103502A1 (en) 2009-05-15 2016-12-14 Intersect ENT, Inc. Expandable devices and methods therefor
EP3636227B1 (en) 2013-03-14 2024-08-28 Intersect ENT, Inc. Systems and devices for treating a sinus condition
TWI503625B (zh) 2013-08-23 2015-10-11 Ind Tech Res Inst 感光性組成物與光阻
CN113679931A (zh) 2015-01-22 2021-11-23 因特尔赛克特耳鼻喉公司 药物涂覆的气囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
DE3204504A1 (de) * 1982-02-10 1983-08-18 Henkel KGaA, 4000 Düsseldorf Neue schwerfluechtige mono- und/oder bis-(meth)-acrylate und ihre verwendung
EP0085944B1 (de) * 1982-02-10 1986-04-09 Henkel Kommanditgesellschaft auf Aktien Chirurgische Bindemittelsysteme zum Verkleben von körpereigenem Hartgewebe gewünschtenfalls mit Kunststoff und/oder Metall
DE3716302C2 (de) * 1987-05-15 1996-02-01 Henkel Kgaa Verbesserte resorbierbare Knochenwachse und ihre Verwendung
DE3825211A1 (de) * 1988-07-25 1990-02-01 Henkel Kgaa Verbesserte koerperresorbierbare knochenwachse (iii)
DE3939161A1 (de) * 1989-11-27 1991-05-29 Henkel Kgaa Verbesserte reaktivsysteme und/oder polymermassen fuer den gewebekontakt mit dem lebenden koerper

Also Published As

Publication number Publication date
DE59205311D1 (de) 1996-03-21
DK0580689T3 (da) 1996-06-17
NO933345L (no) 1993-09-20
BR9205903A (pt) 1994-07-05
JPH06506672A (ja) 1994-07-28
DE4112464A1 (de) 1992-10-22
GR3019522T3 (en) 1996-07-31
WO1992018108A1 (de) 1992-10-29
JP3351523B2 (ja) 2002-11-25
EP0580689A1 (de) 1994-02-02
US5538738A (en) 1996-07-23
AU1576092A (en) 1992-11-17
EP0580689B1 (de) 1996-02-07
CA2108680A1 (en) 1992-10-18
AU661303B2 (en) 1995-07-20
NO933345D0 (no) 1993-09-20
ATE133857T1 (de) 1996-02-15
FI934569A (fi) 1993-10-15
FI934569A0 (fi) 1993-10-15

Similar Documents

Publication Publication Date Title
ES2083167T3 (es) Sistemas de retardo mejorados para la liberacion retardada temporalmente de substancias de valor medico y/o biologico a partir de un material soporte de deposito.
DK88385D0 (da) Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
ATE192338T1 (de) Pharmazeutisches präparat zur synergistischen aktivierung natürlicher killerzellen
PT1006935E (pt) Sistema de entrega controlada liquido de alta viscosidade
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
DE69812711D1 (de) Kohlenhydraten verwendbar in feste verabreichungssysteme
DE69432867D1 (de) Zubereitung mit gesteuerter freisetzung
BG101278A (en) Hard systems designed for controlled release of moleculesintroduced in them and methods for their preparation
MY113488A (en) Compounds with growth hormone releasing properties
HU9200249D0 (en) Veterinary product with delayed active agent activity
ES2157418T3 (es) Piensos medicados para animales.
RS20070379A (en) Pharmaceutical compositions of tizoxanide and nitazoxide
BR0207827A (pt) Método de preparação de uma micropartìcula homogênea que compreende um inibidor de h+/k+-atpase ácido lábil, micropartìcula, composição farmacêutica, método para prevenir ou tratar uma doença relacionada com o ácido gástrico em um mamìfero, e, uso de uma micropartìcula
ES2095817T1 (es) Composicion y sistema de administracion oral para animales.
ATE145821T1 (de) Zusammenfassung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselbe
ES2182983T3 (es) Formulaciones para la liberacion de peptidos.
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템
ATE499069T1 (de) Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen
Ewing Studies on a novel gonadotropin binding inhibitor: Purification, identification and biological characterization of lipopolysaccharide from Serratia liquefaciens.
KR910015302A (ko) 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580689

Country of ref document: ES